durvalumab,Carboplatin,Atezolizumab,Etoposide,serplulimab
astrazeneca,roche,fosun pharmaceuticals
['caspian', 'sclc']
astrum-006 interim analysls presented - medlan fu 12.3 months addition of pd-1 inhibitor to standard chemo in es-sclc improves os with no new safety signals outcome data similar to caspian &amp; impower 133 #asco22 
Radiation Oncologist and Clinical Director, wouldbe cyclist, sometimes pianist. Views are my own, RTs not